Literature DB >> 2577865

Multiple negative elements upstream of the murine c-myc gene share nuclear factor binding sites with SV40 and polyoma enhancers.

G Weisinger1, E F Remmers, P Hearing, K B Marcu.   

Abstract

We previously identified a 716 bp DNA segment, 424 to 1140 bp 5' of the murine c-myc gene, which exhibited the properties of a transcriptional 'dehancer' because it negated the effects of the SV40 enhancer (Remmers et al., 1986). Here, we show that this 716 bp 'dehancer region' is composed of multiple negative elements each of which functions at a distance of > 1 Kb to inhibit the SV40 enhancer. One of these negative elements displays lymphoid cell specificity. HeLa cell nuclear factor binding sites are found within these negative effector sequences. One of these binding sites is related to that of the Py EF-C transcription factor which recognizes a short dyad symmetry element within the polyoma enhancer. Interestingly, a dimer of the Py EF-C recognition sequence exhibited a strong 'dehancer effect' in the pSV2CAT expression vector. These negative elements may function by interfering with transcription factors required for SV40 enhancer activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2577865

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.

Authors:  Y Katan; R Agami; Y Shaul
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

2.  Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.

Authors:  D Eick
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

3.  Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone.

Authors:  D A Wolf; F Kohlhuber; P Schulz; F Fittler; D Eick
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.